FrancophonIA/ELRC3.0 huggingface dataset:
English: Levitra is used to treat adult men (aged 18 years or over) with erectile dysfunction (sometimes called impotence), when they cannot get or keep a hard penis (erection) sufficient for satisfactory sexual activity.
Slovenian: Zdravilo Levitra se uporablja za zdravljenje erektilne disfunkcije (imenovane tudi impotenca) pri odraslih moških (starejših od 18 let), kadar ne zmorejo doseči ali ohraniti takšne erekcije penisa, ki omogoča zadovoljivo spolno dejavnost.
English: It must also not be used in patients who have ever had loss of vision because of a problem with blood flow to the nerve in the eye (non-arteritic anterior ischemic optic neuropathy or NAION).
Slovenian: Prav tako ga ne smejo jemati bolniki, ki so kadar koli imeli težave z vidom zaradi dotoka krvi v očesni živec (nearteritična anteriorna ishemična optična nevropatija - NAION).
English: In addition, Levitra must not be taken with medicines known as guanylate cyclase stimulators, including riociguat (used to treat pulmonary hypertension [high blood pressure in the lungs]).
Slovenian: Poleg tega se ne jemati skupaj z zdravili, imenovanimi spodbujevalci gvanilat ciklaze, vključno z riocigvatom (zdravilom za zdravljenje pljučne hipertenzije, tj. visokega krvnega tlaka v pljučih).
English: Levitra must not be taken with nitrates (medicines used to treat angina).
Slovenian: Zdravilo Levitra se ne sme jemati skupaj z nitrati (zdravili za zdravljenje angine pektoris).
English: The dose of the film-coated tablets may be increased to a maximum of 20 mg or decreased to 5 mg, depending on the effectiveness of treatment and any side effects.
Slovenian: Odmerek filmsko obloženih tablet se lahko glede na učinkovitost zdravljenja in morebitne neželene učinke poveča na 20 mg ali zmanjša na 5 mg.
English: For the full list of all side effects reported with Levitra, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Levitra, glejte navodilo za uporabo.
English: One of these studies was carried out in diabetic men and another in men who had had their prostate gland removed.
Slovenian: V eno študijo so bili vključeni moški s sladkorno boleznijo, v drugo pa bolniki, ki jim je bila odstranjena prostata.
English: The dose may need to be adjusted in patients taking other medicines that block enzymes that break down Levitra.
Slovenian: Pri osebah, ki jemljejo druga zdravila, ki zavirajo encime, ki razgrajujejo zdravilo Levitra, bo odmerek morda treba prilagoditi.
English: By blocking the breakdown of cGMP, Levitra restores erectile function.
Slovenian: Zdravilo Levitra z zaviranjem razgradnje cGMP ponovno vzpostavi erektilno funkcijo.
English: How does Levitra work?
Slovenian: Kako zdravilo Levitra deluje?
English: What is Levitra used for?
Slovenian: Za kaj se zdravilo Levitra uporablja?
English: A starting dose of 5 mg should be considered for patients with mild and moderate liver problems or severe kidney problems.
Slovenian: Bolniki z blagimi ali zmernimi težavami z jetri ali resnimi motnjami v delovanju ledvic naj začnejo s 5-miligramskim odmerkom.
English: How has Levitra been studied?
Slovenian: Kako je bilo zdravilo Levitra raziskano?
English: How is Levitra used?
Slovenian: Kako se zdravilo Levitra uporablja?
English: What is Levitra?
Slovenian: Kaj je zdravilo Levitra?
English: For Levitra to be effective, sexual stimulation is required.
Slovenian: Zdravilo Levitra je učinkovito le ob spolnem vzburjenju.
English: If Levitra film-coated tablets are taken with a high fat meal, the onset of activity may be delayed.
Slovenian: Zdravilo Levitra v obliki filmsko obloženih tablet lahko začne učinkovati pozneje, če se zaužije s hrano, ki vsebuje veliko maščob.
English: Monday Tuesday Wednesday Thursday Friday Saturday Sunday
Slovenian: DRUGI PODATKI ponedeljek torek sreda četrtek petek sobota nedelja
English: - if the patient is less than 2 years of age.
Slovenian: - če je bolnik mlajši od 2 let.
English: Via Provinciale Schito 131 80058 Torre Annunziata (NA) Italy
Slovenian: Via Provinciale Schito 131 80058 Torre Annunziata (NA) Italija
English: Some side effects can be serious (frequency not known):
Slovenian: Nekateri neželeni učinki so lahko resni (pogostnost neznana):
English: The AUC is 50% higher in elderly (> 65 years) than in young subjects.
Slovenian: AUC je pri starejših (> 65 let) 50 % večja kot pri mladih osebah.
English: The mean half-life is about 40 hours (range 34-41 hours).
Slovenian: Izločanje Povprečen razpolovni čas je približno 40 ur (v okviru 34 - 41 ur).
English: Rasilez with food and drink
Slovenian: Zdravilo Rasilez skupaj s hrano in pijačo
English: Date of latest renewal: 22 May 2017
Slovenian: Datum prve odobritve: 22. avgust 2007 Datum zadnjega podaljšanja: 22. maj 2017
English: You may need to stop Rasilez.
Slovenian: Morda boste morali prenehati z jemanjem zdravila Rasilez.
English: Your doctor will normally advise you to stop taking this medicine before you become pregnant and will advise you to take another medicine instead of this medicine.
Slovenian: Zdravnik vam bo praviloma svetoval, da prenehate z jemanjem tega zdravila še preden zanosite in vam bo svetoval jemanje drugega zdravila namesto tega.
English: Palpitations, oedema peripheral
Slovenian: palpitacije, periferni edemi
English: It is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Slovenian: Jemanje tega zdravila med zgodnjo nosečnostjo ni priporočljivo, ko pa ste noseči več kot 3 mesece, ga ne smete jemati, ker lahko uporaba po tretjem mesecu nosečnosti povzroči resno škodo vašemu otroku.
English: If you have severe and persistent diarrhoea you should stop taking Rasilez.
Slovenian: Če imate hudo in trdovratno drisko, morate prenehati z jemanjem zdravila Rasilez.
English: Your doctor may prescribe this medicine together with other medicines used to treat high blood pressure.
Slovenian: Zdravnik vam lahko predpiše to zdravilo skupaj z drugimi zdravili za zdravljenje visokega krvnega tlaka.
English: This medicine must not be used in babies from birth to less than 2 years of age.
Slovenian: Tega zdravila se nikakor ne sme uporabljati pri dojenčkih od rojstva do dopolnjenega 2. leta starosti,
English: Do not take this medicine if you are pregnant (see section “Do not take Rasilez”).
Slovenian: Če ste noseči, ne jemljite tega zdravila (glejte poglavje "Ne jemljite zdravila Rasilez").
English: Other medicines and Rasilez
Slovenian: Druga zdravila in zdravilo Rasilez
English: See also section “Do not take Rasilez”.
Slovenian: Glejte tudi poglavje »Ne jemljite zdravila Rasilez«.
English: The European Medicines Agency has deferred the obligation to submit the results of studies with aliskiren in one or more subsets of the paediatric population in hypertension (see section 4.2 for information on paediatric use).
Slovenian: Evropska agencija za zdravila je začasno odložila zahtevo za predložitev rezultatov študij z aliskirenom za eno ali več podskupin pediatrične populacije pri hipertenziji (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
English: angioedema without any known cause.
Slovenian: prirojeni angioedem; angioedem brez znanega vzroka;
English: Fruit juice and drinks containing plant extracts
Slovenian: Sadni sok in napitki, ki vsebujejo rastlinske izvlečke
English: If you forget to take Rasilez
Slovenian: Če ste pozabili vzeti zdravilo Rasilez
English: In experimental animals, it has been shown that P-gp is a major determinant of Rasilez bioavailability.
Slovenian: Na poskusnih živalih se je pokazalo, da je P-gp glavna determinanta biološke uporabnosti zdravila Rasilez.
English: When driving vehicles or using machines it must be borne in mind that dizziness or drowsiness may occasionally occur when taking Rasilez.
Slovenian: Pri vožnji in uporabi strojev je treba upoštevati, da lahko med jemanjem zdravila Rasilez občasno pride do omotice ali zaspanosti.
English: What Rasilez is and what it is used for What you need to know before you take Rasilez How to take Rasilez
Slovenian: Kaj je zdravilo Rasilez in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Rasilez Kako jemati zdravilo Rasilez
English: There are no clinical data on fertility.
Slovenian: Kliničnih podatkov o vplivu na plodnost ni.
English: **Including one case of ‘liver failure fulminant' reported in the post-marketing experience, for which a causal relationship with aliskiren cannot be excluded.
Slovenian: **vključno z enim primerom “fulminantne odpovedi jeter”, o katerem so poročali med izkušnjami v obdobju trženja zdravila in pri katerem vzročne povezanosti z aliskirenom ni mogoče izključiti
English: Aliskiren should not be used during breast-feeding.
Slovenian: Aliskirena se ne sme uporabljati v času dojenja.
English: Nausea, vomiting
Slovenian: navzea, bruhanje
English: Serious adverse reactions include anaphylactic reaction and angioedema which have been reported in post-marketing experience and may occur rarely (less than 1 case per 1,000 patients).
Slovenian: Resni neželeni učinki vključujejo anafilaktično reakcijo in angioedem, o katerih so poročali med izkušnjami v obdobju trženja zdravila, pojavljata pa se redko (manj kot 1 primer na 1.000 bolnikov).
English: Use of Rasilez is not recommended in this population.
Slovenian: Zdravila Rasilez ne uporabljajte pri tej populaciji.
English: If pregnancy is detected during therapy, treatment should be discontinued accordingly.
Slovenian: V primeru, da se med zdravljenjem izkaže, da je ženska noseča, je treba zdravljenje v skladu s tem prekiniti.
English: In the event of severe and persistent diarrhoea, Rasilez therapy should be stopped (see section 4.8).
Slovenian: V primeru hude ali persistentne driske je treba zdravljenje z zdravilom Rasilez prekiniti (glejte poglavje 4.8).
English: Co-administration of aliskiren with either metformin (↓28%), amlodipine (↑29%) or cimetidine
Slovenian: Ob sočasni uporabi aliskirena z metforminom (↓28 %), amlodipinom (↑29 %) ali s cimetidinom
English: If anaphylactic reactions or angioedema occur, treatment should be promptly discontinued and appropriate therapy and monitoring provided until complete and sustained resolution of signs and symptoms has occurred.
Slovenian: Če pride do anafilaktične reakcije ali angioedema, je treba zdravljenje z aliskirenom takoj prekiniti in poskrbeti za ustrezno zdravljenje in spremljanje bolnika, dokler znaki in simptomi niso v celoti in trajno odpravljeni.
English: The safety and efficacy of Rasilez in children aged 6 to 17 years have not yet been established.
Slovenian: Varnost in učinkovitost zdravila Rasilez pri otrocih, starih 6 do 17 let, nista bili dokazani.
English: The volume or salt depletion should be corrected prior to administration of Rasilez, or the treatment should start under close medical supervision.
Slovenian: Hipovolemijo ali primanjkljaj natrija je treba odpraviti pred dajanjem zdravila Rasilez ali pa je treba zdravljenje uvajati pod strogim zdravniškim nadzorom.
English: It is unknown whether aliskiren/metabolites are excreted in human milk.
Slovenian: Ni znano, ali se aliskiren/presnovki izločajo v materino mleko.
English: Overall, the mean age of the patients was 11.8 years with 48.6% of patients being in the 6-11 years age group and 51.4% in the 12-17 years age group.
Slovenian: 48,6 % bolnikov v starostni skupini 6-11 let, 51,4 % pa v starostni skupini 12-17 let.
English: - ketoconazole, a medicine used to treat fungal infections.
Slovenian: - ketokonazol, to je zdravilo za zdravljenje glivičnih okužb;
English: It should not be used in children from 2 to less than 6 years of age, and is not recommended for use in children and adolescents from 6 to less than 18 years of age.
Slovenian: ne bi ga smeli uporabljati pri otrocih po dopolnjenem 2. letu in pred dopolnjenim 6. letom starosti, njegova uporaba pa ni priporočena niti pri otrocih in mladostnikih, ki so stari vsaj 6 in manj kot 18 let, saj varnost in koristi tega zdravila pri tej populaciji niso znane
English: Do not take Rasilez - if you are allergic to aliskiren or any of the other ingredients of this medicine (listed in section 6).
Slovenian: - če ste alergični na aliskiren ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: Table 1 Immune system disorders Rare:
Slovenian: Preglednica 1 Bolezni imunskega sistema redki:
English: However, the efficacy of aliskiren was similar when taken with a light meal or under fasted state.
Slovenian: Učinkovitost aliskirena je podobna v primeru, ko se ga jemlje z lahkimi obroki, ali na tešče.
English: Mean weight was 68.0 kg with 57.7% of patients having BMI greater than or equal to the 95th percentile for age and gender.
Slovenian: Povprečna telesna masa bolnikov je bila 68,0 kg, pri čemer je imelo 57,7 % bolnikov indeks telesne mase (ITM) višji ali enak vrednosti 95. percentila za starost in spol.
English: - Children from birth to less than 2 years (see sections 4.2 and 5.3).
Slovenian: - Otroci pred dopolnjenim 2. letom starosti (glejte poglavji 4.2 in 5.3).
English: The starting dose in each group was assigned depending on weight with three groups: ≥20 to <50 kg, ≥50 to <80 kg, and ≥80 to ≤150 kg.
Slovenian: Začetne odmerke za posamezno skupino so določili glede na telesno maso v treh skupinah: ≥20 do <50 kg, ≥50 do <80 kg in ≥80 do ≤150 kg.
English: The safety and efficacy of aliskiren in children aged 6 to 17 years have not yet been established.
Slovenian: Varnost in učinkovitost aliskirena pri otrocih, starih 6 do 17 let, še nista bili dokazani.
English: Therefore, drinks containing plant extracts, including herbal teas, should not be taken together with aliskiren (see section 4.2)
Slovenian: Iz tega razloga se napitkov, ki vsebujejo rastlinske izvlečke, vključno z zeliščnimi čaji, ne sme uživati skupaj z aliskirenom (glejte poglavje 4.2).
English: Acute renal failure, renal impairment
Slovenian: akutna ledvična odpoved, okvara ledvic
English: Safety pharmacology studies did not reveal any adverse effects on central nervous, respiratory or cardiovascular function.
Slovenian: Farmakološke študije varnosti aliskirena niso razkrile nobenega neželenega učinka na centralno živčevje, dihanje in delovanje srčnožilnega sistema.
English: Aliskiren has been evaluated for safety in more than 7,800 patients, including over 2,300 treated for over 6 months, and more than 1,200 for over 1 year.
Slovenian: Varnost zdravila Rasilez so ocenjevali pri več kot 7.800 bolnikih, med drugim pri več kot 2.300 bolnikih, ki so bili zdravljeni več kot 6 mesecev, in pri več kot 1.200 bolnikih, ki so bili zdravljeni več kot 1 leto.
English: The treatment with aliskiren was well tolerated in this study.
Slovenian: Preiskovanci v tej študiji so aliskiren dobro prenašali.
English: However, since aliskiren has been shown to be a substrate for the organic anion-transporting polypeptide 1A2 (OATP1A2) (see section “Organic anion transporting polypeptide (OATP” below) inhibitors), there is a potential for aliskiren to reduce plasma torasemide exposure by an interference with the absorption process.
Slovenian: Ker pa so dokazali, da je aliskiren substrat polipeptidnega prenašalca organskih anionov 1A2 (OATP1A2) (glejte spodnje poglavje »Medsebojno delovanje z zaviralci polipeptidnega prenašalca organskih anionov«), obstaja možnost, da aliskiren z oviranjem procesa absorpcije znižuje izpostavljenost torasemidu v plazmi.
English: Treatment of essential hypertension in adults.
Slovenian: 4.1 Terapevtske indikacije Zdravljenje esencialne hipertenzije pri odraslih.
English: Rare (may affect up to 1 in 1,000 people): increased level of creatinine in the blood, decreased level of haemoglobin in the blood (anaemia), decreased level of red blood cells, red skin (erythema).
Slovenian: Redki (lahko se pojavijo pri največ 1 od 1.000 ljudi): zvišana raven kreatinina v krvi, znižana raven hemoglobina v krvi (anemija), znižana raven rdečih krvnih celic, rdečina (eritem).
English: The available clinical data did not indicate that higher doses of torasemide were used after co-administration with aliskiren.
Slovenian: Razpoložljivi klinični podatki ne kažejo, da so po sočasnem odmerjanju z aliskirenom uporabljali višje odmerke torasemida.
English: Therefore, because of the risk of therapeutic failure, fruit juice should not be taken together with aliskiren.
Slovenian: Ker bi torej lahko prišlo do zmanjšanja terapevtskega učinka, se sadnega soka ne sme uživati skupaj z aliskirenom.
English: (↑19%) resulted in between 20% and 30% change in Cmax or AUC of Rasilez.
Slovenian: (↑19 %) sta se Cmax ali AUC zdravila Rasilez spremenila za 20 % do 30 %.
English: Hypersensitivity reactions including anaphylactic reactions and angioedema In controlled clinical studies, angioedema and hypersensitivity reactions occurred rarely during treatment with aliskiren with rates comparable to treatment with placebo or comparators.
Slovenian: Preobčutljivostne reakcije, vključno z anafilaktičnimi reakcijami in angioedemom V kontroliranih kliničnih študijah je med zdravljenjem z aliskirenom redko prišlo do angioedema in preobčutljivostnih reakcij in sicer s pogostnostjo, ki je bila primerljiva z zdravljenjem s placebom ali primerjalnimi zdravili.
English: In addition, an increased incidence of adverse events was observed with aliskiren compared to placebo (38.2% versus 30.3%).
Slovenian: Poleg tega so pri uporabi aliskirena v primerjavi s placebom opažali povečano pogostnost neželenih dogodkov (38,2 % v primerjavi s
English: Talk to your doctor before taking Rasilez: - if you are taking a diuretic (a type of medicine also known as “water” tablets which increases the amount of urine you produce).
Slovenian: Pred začetkom jemanja zdravila Rasilez se posvetujte z zdravnikom: - kadar jemljete diuretike (vrsta zdravil za odvajanje vode, ki povečuje količino urina, ki nastaja v telesu);
English: Not known (frequency cannot be estimated from the available data): spinning sensation, low level of sodium in the blood, shortness of breath, nausea, vomiting, signs of liver disorder (nausea, loss of appetite, dark coloured urine or yellowing of skin and eyes).
Slovenian: Pogostnost neznana (ni mogoče oceniti iz razpoložljivih podatkov): vrtoglavica, znižana raven natrija v krvi, zadihanost, občutek siljenja na bruhanje, bruhanje, znaki bolezni jeter (občutek siljenja na bruhanje, izguba apetita, temno obarvan urin ali porumenevanje kože in oči).
English: Uncommon (may affect up to 1 in 100 people): Skin rash (this may also be a sign of allergic reactions or angioedema - see “Rare” side effects below), kidney problems including acute renal failure (severely decreased urine output), swelling of hands, ankles or feet (peripheral oedema), severe skin reactions (toxic epidermal necrolysis and/or oral mucosal reactions - red skin, blistering of the lips, eyes or mouth, skin peeling, fever), low blood pressure, palpitations, cough, itching, itchy rash (urticaria), increased liver enzymes.
Slovenian: Občasni (lahko se pojavijo se pri največ 1 od 100 ljudi): kožni izpuščaj (to je lahko tudi znak alergijskih reakcij ali angioedema - glejte "Redki" neželeni učinki, spodaj), težave z ledvicami, vključno z akutno ledvično odpovedjo (zelo zmanjšanim nastajanjem urina), otekanje rok, gležnjev ali stopal (periferni edemi), hude kožne reakcije (toksična epidermalna nekroliza in/ali reakcije ustne sluznice - rdeča koža, nastajanje mehurjev na ustnicah, očeh ali v ustih, luščenje kože, zvišana telesna temperatura), nizek krvni tlak, palpitacije, kašelj, srbenje, srbeč izpuščaj (koprivnica), zvišane vrednosti jetrnih encimov.
English: You should avoid taking this medicine together with fruit juice and/or drinks containing plant extracts (including herbal teas), as it could cause a decrease in the effectiveness of this medicine.
Slovenian: Izogibati se morate jemanju tega zdravila skupaj s sadnim sokom in/ali z napitki, ki vsebujejo rastlinske izvlečke (kar vključuje tudi zeliščne čaje), saj lahko zmanjšajo učinkovitost tega zdravila.
English: Hypotension, syncope, stroke, hyperkalaemia, and decreased renal function (including acute renal failure) have been reported in susceptible individuals, especially if combining medicinal products that affect this system (see section 5.1).
Slovenian: Pri dovzetnih osebah so bile opisane hipotenzija, sinkopa, možganska kap, hiperkaliemija in zmanjšanje delovanja ledvic (vključno z akutno odpovedjo ledvic), zlasti v kombinaciji z zdravili, ki vplivajo na ta sistem (glejte poglavje 5.1).
English: As for any medicine that acts directly on the RAAS, alsikiren should not be used during the first trimester of pregnancy or in women planning to become pregnant and is contraindicated during the second and third trimesters (see section 4.3).
Slovenian: Tako kot velja za katerokoli drugo zdravilo, ki deluje neposredno na sistem renin-angiotenzin-aldosteron, tudi aliskirena ne smete uporabljati v prvem trimesečju nosečnosti oziroma pri ženskah, ki načrtujejo nosečnost, poleg tega je kontraindiciran v drugem in tretjem trimesečju nosečnosti (glejte poglavje 4.3).
English: Dual blockade of the renin-angiotensin-aldosterone system (RAAS)
Slovenian: Dvojno zaviranje sistema renin-angiotenzin-aldosteron (RAAS − renin-angiotensin-aldosterone system)
English: - certain types of pain killers called non-steroidal anti-inflammatory medicines (NSAIDs).
Slovenian: - določene vrste zdravil proti bolečinam z imenom nesteroidna protivnetna zdravila.
English: Rasilez 300 mg film-coated tablets EU/1/07/405/011-020
Slovenian: Rasilez 300 mg filmsko obložene tablete EU/1/07/405/011-020
English: Rasilez is contraindicated in children from birth to less than 2 years.
Slovenian: Zdravilo Rasilez je kontraindicirano pri otrocih pred dopolnjenim 2. letom starosti.
English: In addition, due to the possibility of up-titration if medically necessary to control the msSBP, no conclusion can be drawn on the appropriate posology of aliskiren in patients aged 6 to 17 years.
Slovenian: Poleg tega zaradi možnosti zviševanja odmerkov, ki je bilo potrebno za obvladovanje srednje vrednosti sistoličnega krvnega tlaka v sedečem položaju, ni mogoče podati zaključkov o primernosti odmerjanja aliskirena pri bolnikih v starosti 6
English: (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare
Slovenian: Neželeni učinki so razvrščeni po skupinah glede na pogostnost, najpogostejši najprej, po naslednjem dogovoru: zelo pogosti (≥1/10); pogosti (≥1/100 do <1/10); občasni (≥1/1.000 do <1/100); redki (≥1/10.000 do <1/1.000); zelo redki (<1/10.000) in neznana (ni mogoče oceniti iz razpoložljivih podatkov).
English: INFORMATION IN BRAILLE Rasilez 300 mg
Slovenian: PODATKI V BRAILLOVI PISAVI Rasilez 300 mg
English: In clinical studies aliskiren has not been investigated in hypertensive patients with severe renal impairment (serum creatinine ≥ 150 μmol/l or 1.70 mg/dl in women and ≥ 177 μmol/l or 2.00 mg/dl in men and/or estimated GFR < 30 ml/min/1.73 m2), history of dialysis, nephrotic syndrome or renovascular hypertension.
Slovenian: V kliničnih študijah aliskirena niso raziskovali pri hipertenzivnih bolnikih s hudo okvaro ledvic (kreatinin v serumu ≥ 150 μmol/l oziroma 1,70 mg/dl pri ženskah in ≥ 177 μmol/l oziroma 2,00 mg/dl pri moških in/ali ocenjeno GFR < 30 ml/min/1,73 m2), pri bolnikih, ki so se že zdravili z dializo, pri bolnikih z nefrotskim sindromom ali z renovaskularno hipertenzijo.
English: In a 36-week study involving 820 patients with ischaemic left ventricular dysfunction, no changes in ventricular re-modelling as assessed by left ventricular end systolic volume were detected with aliskiren compared to placebo on top of background therapy.
Slovenian: V 36-tedenski študiji pri 820 bolnikih z ishemično disfunkcijo levega prekata niso ugotovili sprememb prekatnega remodeliranja (ocenjenega s končnim sistoličnim volumnom v levem prekatu) z aliskirenom v primerjavi s placebom, dodanima osnovnemu zdravljenju.
English: How to take Rasilez
Slovenian: Kako jemati zdravilo Rasilez
English: The recommended dose of Rasilez is 150 mg once daily.
Slovenian: Odmerjanje Priporočeni odmerek zdravila Rasilez je 150 mg enkrat dnevno.